Follow us on LinkedIn Twitter


The shopping cart is empty
Knows our products
Knows our services
Knows our R+D

PROALT (Protein Alternatives SL)

ProAlt is a young biotechnological company focused on the development and commercialization of biomarker-based assays for cancer diagnosis and clinical management.

The company also offers its own manufactured innovative recombinant proteins and antibodies, and different custom-tailored integral services in protein design and expression. Service offer is performed under individual customer contracts (CRO) to meet biotechnology industry needs.

Special Offers

ProAlt news


PROALT presented at BIO 2017 International Convention in San Diego CA (USA) from 19 to 22 June.

View more





PROALT exhibited at BioSpain 2016 organized by ASEBIO (Spanish Bioindustry Association) in Bilbao, Spain, from 28 to 31 October.

View more


ProAlt events

June 2017

BIO 2017. San Diego (USA) 19-22 June

September 2017

ESMO 2017. Madrid (Spain) 8-12 September

October 2017

AACR-NCI-EORTC 2017. Philadelphia (USA) 26-30 October

November 2017
BIO-EUROPE 2017. Berlin (Germany) 6-8 November

MEDICA 2017. Düsseldorf (Germany) 13-16 November


View more

ProAlt new products

Human Beta-2-Microglobulin recombinant protein

PRO-50077, PRO-50076, PRO-50075,

AB-1011, MAB-010, MAB-011: Human Gelsolin Isoform A (GSN) recombinant protein, Rabbit anti-GSN polyclonal antibody, Mouse Anti-GSN monoclonal antibody

PRO-50074, PRO-50073, AB-1010, MAB-008, MAB-009: Human Ganglioside GM2 activator isoform 1 (GM2AP) recombinant protein, Rabbit anti- GM2AP, polyclonal antibody, Mouse Anti-GM2AP monoclonal antibody


© Developed by Web4Bio